Anil Singhvi explains how to play Indian pharma stocks after Trump imposes 100% tariff on branded drugs

Wait 5 sec.

Trump Tariffs on Pharma Companies: Market expert and Zee Business Managing Editor Anil Singhvi warned that Indian pharma stocks could face short-term volatility after US President Donald Trump announced a 100 per cent tariff on branded and patented drugs imported into the United